US Patent Issued to Universite de Montreal on Nov. 25 for "Pyrido[3,2-dpyrimidine compounds uses thereof for treating a proliferative disease" (Canadian, American Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,842, issued on Nov. 25, was assigned to Universite de Montreal (Montreal).

"Pyrido[3,2-dpyrimidine compounds uses thereof for treating a proliferative disease" was invented by Pierre Louis Beaulieu (Rosemere, Canada), Eric Beaulieu (Mercier, Canada), Joanne Tan (San Mateo, Calif.), Yannick Rose (Montreal, Canada), Michael Dore (Saint-Bruno-de-Montarville, Canada), Doris Schuetz (Montreal, Canada), Mukund Ghavre (Saint-Laurent, Canada) and Jacques Banville (Saint-Hubert, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds, compositions and their use in the treatment of a proliferative disease or condition such as a said proliferative dise...